首页|米非司酮联合地屈孕酮治疗人流术后宫腔残留的疗效分析

米非司酮联合地屈孕酮治疗人流术后宫腔残留的疗效分析

扫码查看
目的 探究米非司酮联合地屈孕酮治疗人流术后宫腔残留的疗效.方法 选取本院60例人流术后宫腔残留疾病患者,按照随机数字表法分为两组,各30例.对照组采用单用米非司酮治疗,观察组采用米非司酮联合地屈孕酮治疗.对比两组治疗效果.结果 观察组5项康复时间均短于对照组,差异有统计学意义(P<0.05).观察组治疗总有效率为96.67%,显著高于对照组的80.00%,差异有统计学意义(P<0.05).观察组不良反应总发生率低于对照组,差异有统计学意义(P<0.05).结论 人流术后宫腔残留采用米非司酮联合地屈孕酮治疗,可加快宫腔残留妊娠物排出,加快子宫康复速度,提高治疗效果,减少不良反应.
Analysis of the therapeutic effect of mifepristone combined with dexamethasone in the treatment of residual uterine cavity after abortion
Objective To explore the therapeutic effect of mifepristone combined with dexamethasone in the treatment of residual uterine cavity after abortion.Methods 60 patients with residual uterine cavity diseases after abortion in our hospital were selected and randomly divided into two groups,each with 30 cases,using a random number table method.The control group was treated with mifepristone alone,while the observation group was treated with mifepristone combined with dexmedetone.Compare the therapeutic effects of two groups.Results The rehabilitation time of the observation group was shorter than that of the control group,and the difference was statistically significant(P<0.05).The total effective rate of the observation group was 96.67%,significantly higher than the 80.00%of the control group,and the difference was statistically significant(P<0.05).The total incidence of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclusion The treatment of residual pregnancy in the uterine cavity after abortion using mifepristone combined with dexamethasone can accelerate the discharge of residual pregnancy,accelerate uterine recovery,improve treatment effectiveness,and reduce adverse reactions.

Residual uterine cavity after abortionMifepristoneDeinorgestrelTreatment effect

彭丹、陈梅、张艳新、卢珍梅

展开 >

广西壮族自治区妇幼保健院 妇科,广西 南宁 530005

人流术后宫腔残留 米非司酮 地屈孕酮 治疗效果

广西中医药局自筹经费科研课题

GZZC2020212

2024

实用妇科内分泌电子杂志

实用妇科内分泌电子杂志

ISSN:
年,卷(期):2024.11(3)
  • 13